Filing Flows › Industrials › Bodhi Tree Biotechnology (BDTB)
Bodhi Tree Biotechnology (BDTB) earnings and revenue breakdown
Latest: Q3 FY26 · 10-Q filed Aug 14, 2026 · Bodhi Tree Biotechnology (BDTB) Q3 FY26 earnings results →
Q3 FY26 232¢ of every $1 of revenue lost · operating margin -232.0%
Bodhi Tree Biotechnology made $10K in Q3 FY26. Operating margin -232.0%, net loss $23K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 14, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $10K in Q3 FY26, down 33% from the previous quarter.
Operating costs exceeded revenue by $23K, an operating margin of -232.0%. The quarter ended with a net loss of $23K, narrower than the previous quarter's $29K loss.
Operating cash flow was −$19K. Working capital and other items added $4K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 FY26 | 10-Q | Aug 14, 2026 | $10K | — | -232.0% | −$23K | −$19K |
| Q2 FY26 | 10-Q | May 14, 2026 | $15K | — | -186.2% | −$29K | −$25K |
| Q4 FY25 | 10-K | Dec 29, 2025 | $12K | -40% | -89.1% | −$11K | −$10K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Bodhi Tree Biotechnology
Bodhi Tree Biotechnology Inc. (“us,” “our,” “we,” or the “Company”) was incorporated in the State of Delaware on December 12, 2023. We are an early-stage consulting company focused on providing plant-based menu design, recipe development, and vegetarian diet consulting services. Our executive office is located in Danville, California. We believe that our menu design, recipe development, and consulting services align with increasing consumer interest in flexitarian, vegetarian, and organic lifestyles. Industry studies indicate that consumers increasingly seek healthier recipe options and sustainable dietary habits. Our strategy is to introduce the attributes of a vegetarian lifestyle and build a connection with consumers who value nutritious, sustainably sourced, and plant-based meals and recipes.
In its own words, from its 10-K, filed Dec 29, 2025.
Bodhi Tree Biotechnology against its Services-Management Consulting Services peers
The largest companies of the same SEC industry, each at its latest quarter. Operating margin: -232.0% against the peers' median 8.9%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| BDTB Bodhi Tree Biotechnology | Q3 FY26 | $10K | — | -232.0% |
| BAH Booz Allen Hamilton Holding | Q2 FY27 | $2.8B | -4% | 8.8% |
| G Genpact | Q3 2026 | $1.4B | +7% | 15.2% |
| ASTH Astrana Health | Q3 2026 | $1.0B | +7% | 3.9% |
| FCN FTI Consulting | Q3 2026 | $1.0B | +6% | 8.9% |
| HURN Huron Consulting Group | Q3 2026 | $491M | +11% | 12.0% |
| ICFI ICF International | Q3 2026 | $470M | +1% | 9.3% |
| ONT Onterris | Q3 2026 | $203M | -10% | 6.0% |
| EXPO Exponent | Q3 2026 | $174M | +18% | 24.1% |
Source: Bodhi Tree Biotechnology 10-Q on SEC EDGAR · CIK 2041531 · Services-Management Consulting Services
More on BDTB
History
Every quarter: Q3 FY26 results · Q2 FY26 results · Q4 FY25 results